Editor's Picks

Alarum Technologies Ltd. (NASDAQ:ALAR) Faces Legal Challenges Ahead of Q3 Earnings Report

  • Alarum Technologies Ltd. is set to release its Q3 earnings, with analysts forecasting an EPS of $0.02 on $12.2 million in revenue.
  • The company is embroiled in a class action lawsuit, alleging its NetNut subsidiary was involved in malicious online traffic, with a lead plaintiff deadline of October 5, 2026.
  • Despite legal woes, Alarum’s financial health appears stable, marked by a low debt-to-equity ratio of 0.08 and a strong current ratio of 2.58.

Alarum Technologies Ltd. (NASDAQ:ALAR), a company specializing in internet access solutions, is preparing to release its next quarterly earnings report on September 2, 2026. The company operates in the technology sector, with its subsidiary NetNut providing proxy network services. Investors are watching closely as Wall Street analysts forecast an earnings per share (EPS) of $0.02 on revenue of $12.2 million.

This earnings announcement comes as Alarum faces significant legal challenges. The company is the subject of a class action lawsuit following a July 2, 2026, report from Reuters. The article stated that Google (NASDAQ:GOOGL) disrupted a network used for malicious online traffic, identifying Alarum’s subsidiary, NetNut, as being involved in “related malware command-and-control operations.”

Several law firms, including Glancy Prongay Wolke & Rotter LLP, are reminding investors of an October 5, 2026, deadline to file as lead plaintiff. The lawsuit alleges that Alarum made false statements and that its NetNut subsidiary linked customers’ home devices to other networks without their consent between March 20, 2025, and July 2, 2026.

Despite these legal issues, Alarum’s financial data shows a trailing price-to-earnings (P/E) ratio of 8.60. This ratio suggests how much investors are willing to pay for each dollar of the company’s earnings. The company also has a price-to-sales ratio of 0.25, which compares the stock price to its revenues.

From a financial health perspective, the company’s balance sheet appears stable. It has a low debt-to-equity ratio of 0.08, indicating it relies more on equity than debt to finance its assets. Furthermore, its current ratio is 2.58, showing a strong ability to meet its short-term financial obligations.

Leave a comment

Your email address will not be published. Required fields are marked *